Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318822 · ClinicalTrials.gov registry record
Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 200
- Enrollment target
NCT03318822: Completed study, sponsored by Emory University.
NCT03318822 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03318822 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the usability and tolerability of this jugular vein compression device in a population of helmeted and non-helmeted competitive high school, collegiate and professional athletes in the sports of football and rugby. This study differs from previous work in that it is designed to capture additional data related to the athlete experience wearing the jugular vein compression device in older and more elite playing levels.
Primary Outcome
measure subject tolerability to wearing the device via weekly survey
Interventions
- DEVICE Q-Collar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-12-31 |
What the finished NCT03318822 record still lists
NCT03318822 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Q-Collar is the first listed.
NCT03318822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03318822 about?
NCT03318822 is a clinical study titled "Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport". The purpose of the study is to assess the usability and tolerability of this jugular vein compression device in a population of helmeted and non-helmeted competitive high school, collegiate and professional athletes in the sports of football and rugby. This study differs from previous work in that i...
What is the current status of trial NCT03318822?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-08-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03318822?
The interventions under investigation include: Q-Collar (DEVICE).
Who is sponsoring clinical trial NCT03318822?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI